Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GeneMind Biosciences logo — Advancing precision in gene sequencing through relentless in...

GeneMind Biosciences

Advancing precision in gene sequencing through relentless innovation and exploration, we empower clinicians and researchers to conquer new heights in genomics.

Founded 2012 201-500 employees Series C Total: $540.00M Biotechnology, Life Sciences

General Information

Company Name GeneMind Biosciences
Founded Year 2012
Employees 201-500
Industries Biotechnology, Life Sciences
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with GeneMind Biosciences. To contact GeneMind Biosciences, visit genemind.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GeneMind Biosciences compare?

A PDF of GeneMind Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GeneMind Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GeneMind Biosciences

GeneMind Biosciences, founded in 2012, is a pioneering player in the Biotechnology industry. The company's relentless pursuit of innovation and exploration has led to the development of a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences aims to empower clinicians and researchers by providing superior gene sequencing solutions. The recent CNY400.00M Series C investment on 02 August 2023 shows strong support from key investors including KingMed Diagnostics, Guoxin Investment, SZHTI Group, Caixin Capital, Changzhou Shuangye Venture Capital, Guochuang Zhiyuan. This signifies a high level of confidence in GeneMind's potential for growth and success in the genomics field. The company's innovative technology represents a pinnacle achievement in gene sequencing, enabling entrepreneurs to propel their research and advancements. GeneMind's steadfast efforts in tackling obstacles have positioned them to conquer new heights in genomics, shaping the future of precision gene sequencing.

Business keywords: Gene sequencing, Precision medicine, Genomics, Single-molecule sequencing, Research and development, Innovation, Clinical solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY400.00M 6
KingMed Diagnostics 深圳市高新投集团有限公司 Guoxin Investment
KingMed Diagnostics, 深圳市高新投集团有限公司 +4
02 Aug 2023
Series B CNY140.00M 1
Sincere Capital
Sincere Capital
01 Sep 2020
Venture Round Undisclosed 1
Tengye Ventures
Tengye Ventures
01 Jan 2014

GeneMind Biosciences Alternatives & Competitors

View All Alternatives
GeneMind Biosciences vs
Aniling
Aniling Spain

Accelerating Epigenomics for Precision Medicine against cancer

Seed
12 employees
Biotechnology, Health Care
GeneMind Biosciences vs
Annoroad Genomics
Annoroad Genomics China

Annoroad, headquartered in Beijing, is the China’s leading developer and marketer on genomic innovat...

Series C
16 employees
Biotechnology, Health Care
GeneMind Biosciences vs
Ficus Biotechnology
Ficus Biotechnology Turkey

Next-generation technologies in the genomics era

1 employees
Biotechnology, Deep Tech
View all alternatives

FAQ About GeneMind Biosciences

Advancing precision in gene sequencing through relentless innovation and exploration, we empower clinicians and researchers to conquer new heights in genomics.
GeneMind Biosciences was founded in 2012.
GeneMind Biosciences operates in Biotechnology and Life Sciences. Its work centres on Gene sequencing, Precision medicine, Genomics and Single-molecule sequencing.
GeneMind Biosciences has approximately 201-500 employees.
GeneMind Biosciences has completed 3 funding rounds, raising a total of $540.00M. The latest funding stage is Series C.
Top alternatives and competitors to GeneMind Biosciences include Aniling, Annoroad Genomics, Ficus Biotechnology, 54gene, G+FLAS Life Sciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GeneMind Biosciences and Aniling are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GeneMind Biosciences, https://bouncewatch.com/company/genemind-biosciences, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout